Channelpedia

Cav2.2 Channel

265 automatically matched literature references

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

7

Lu VB et al. Strategies for Investigating G-Protein Modulation of Voltage-Gated Ca2+ Channels.
Cold Spring Harb Protoc, 2016 , 2016 (pdb.top087072).

10

Chang CY et al. Apigenin, a natural flavonoid, inhibits glutamate release in the rat hippocampus.
Eur. J. Pharmacol., 2015 Sep 5 , 762 (72-81).

16

Butler MG et al. Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.
Am. J. Med. Genet. B Neuropsychiatr. Genet., 2015 Oct 13 , ().

17

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

18

20

21

Ament SA et al. Rare variants in neuronal excitability genes influence risk for bipolar disorder.
Proc. Natl. Acad. Sci. U.S.A., 2015 Mar 17 , 112 (3576-81).

23

Plourde M et al. Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major.
Mol. Biochem. Parasitol., 2015 Jun , 201 (108-11).

24

Weiss N The first disease connection for Cav2.2 channels.
Gen. Physiol. Biophys., 2015 Jul , 34 (217-9).

26

Liu F et al. 14-3-3τ promotes surface expression of Cav2.2 (α1B) Ca2+ channels.
J. Biol. Chem., 2015 Jan 30 , 290 (2689-98).

28

Groen JL et al. CACNA1B mutation is linked to unique myoclonus-dystonia syndrome.
Hum. Mol. Genet., 2015 Feb 15 , 24 (987-93).

30

Zhou MH et al. Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.
J. Biol. Chem., 2015 Dec 18 , 290 (30616-23).

33

Gleeson EC et al. Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives.
Mar Drugs, 2015 Apr , 13 (2030-45).

37

Fernández-Morales JC et al. Hypoxia-elicited catecholamine release is controlled by L-type as well as N/PQ types of calcium channels in rat embryo chromaffin cells.
Am. J. Physiol., Cell Physiol., 2014 Sep 1 , 307 (C455-65).

39

Felizola SJ et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol., 2014 Oct , 144 Pt B (410-6).

46

Winters MP et al. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
Bioorg. Med. Chem. Lett., 2014 May 1 , 24 (2053-6).

50

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

51

Cassidy JS et al. Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary α2δ-1 subunits.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jun 17 , 111 (8979-84).

52

Ricoy UM et al. Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.
J. Neurophysiol., 2014 Jun 15 , 111 (2404-13).

54

58

Kline CF et al. Ankyrin-B regulates Cav2.1 and Cav2.2 Expression and Targeting.
J. Biol. Chem., 2014 Jan 6 , ().

61

Hernández-Castellanos JM et al. Gβ₂ mimics activation kinetic slowing of CaV2.2 channels by noradrenaline in rat sympathetic neurons.
Biochem. Biophys. Res. Commun., 2014 Feb 28 , 445 (250-4).

66

70

Gandini MA et al. The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels.
Channels (Austin), 2014 , 8 (452-7).

71

Ju W et al. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
Channels (Austin), 2013 May-Jun , 7 (153-9).

73

Ramachandra R et al. Identification of CaV channel types expressed in muscle afferent neurons.
J. Neurophysiol., 2013 Oct , 110 (1535-43).

76

Marques JM et al. CRMP2 tethers kainate receptor activity to cytoskeleton dynamics during neuronal maturation.
J. Neurosci., 2013 Nov 13 , 33 (18298-310).

78

Vivas O et al. PIP₂ hydrolysis is responsible for voltage independent inhibition of CaV2.2 channels in sympathetic neurons.
Biochem. Biophys. Res. Commun., 2013 Mar 8 , 432 (275-80).

79

Almagor L et al. Structural flexibility of CaV1.2 and CaV2.2 I-II proximal linker fragments in solution.
Biophys. J., 2013 Jun 4 , 104 (2392-400).

81

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

84

Sousa SR et al. Venom peptides as a rich source of cav2.2 channel blockers.
Toxins (Basel), 2013 Feb , 5 (286-314).

88

Mukherjee A et al. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania.
Mol. Microbiol., 2013 Apr , 88 (189-202).

93

Mallmann RT et al. Tetraspanin-13 modulates voltage-gated CaV2.2 Ca2+ channels.
Sci Rep, 2013 , 3 (1777).

97

Bravo-Martínez J et al. A novel CaV2.2 channel inhibition by piracetam in peripheral and central neurons.
Exp. Biol. Med. (Maywood), 2012 Oct 1 , 237 (1209-18).

98

Shao PP et al. Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
J. Med. Chem., 2012 Nov 26 , 55 (9847-55).

99

Brittain JM et al. Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.
FEBS Lett., 2012 Nov 2 , 586 (3813-8).

101

103

Marangoudakis S et al. Differential ubiquitination and proteasome regulation of Ca(V)2.2 N-type channel splice isoforms.
J. Neurosci., 2012 Jul 25 , 32 (10365-9).

106

Lopez Soto EJ et al. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Neurosci. Lett., 2012 Aug 15 , 523 (190-4).

109

Yarotskyy V et al. Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.
J. Neurophysiol., 2012 Apr , 107 (1942-51).

113

118

Davies JN et al. Bipartite syntaxin 1A interactions mediate CaV2.2 calcium channel regulation.
Biochem. Biophys. Res. Commun., 2011 Aug 5 , 411 (562-8).

120

Currie KP G protein modulation of CaV2 voltage-gated calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (497-509).

122

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

124

Lötsch J et al. Pharmacogenetics of new analgesics.
, 2010 Oct 13 , ().

132

137

Yarotskyy V et al. Open-state occupancy prevents gating charge relaxation of N-type (CaV2.2) calcium channels.
Biophys. J., 2009 Nov 4 , 97 (2446-55).

141

Yarotskyy V et al. omega-conotoxin GVIA alters gating charge movement of N-type (CaV2.2) calcium channels.
J. Neurophysiol., 2009 Jan , 101 (332-40).

142

Dresviannikov AV et al. Determinants of the voltage dependence of G protein modulation within calcium channel beta subunits.
Pflugers Arch., 2009 Feb , 457 (743-56).

148

Gardezi SR et al. PDLIM5 is not a neuronal CaV2.2 adaptor protein.
Nat. Neurosci., 2009 Aug , 12 (957-8; author reply 958).

149

Hamdi M et al. Arsenic transport by zebrafish aquaglyceroporins.
BMC Mol. Biol., 2009 , 10 (104).

156

Díaz-Cárdenas AF et al. PMA counteracts G protein actions on CaV2.2 channels in rat sympathetic neurons.
Arch. Biochem. Biophys., 2008 May 1 , 473 (1-7).

158

Su X et al. Role of spinal Cav2.2 and Cav2.1 ion channels in bladder nociception.
J. Urol., 2008 Jun , 179 (2464-9).

159

Dray A Neuropathic pain: emerging treatments.
, 2008 Jul , 101 (48-58).

163

Zhang JS et al. [Neurons in the corpus callosum of rats: expression of Cav2.2 and their connection]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2008 Feb , 33 (99-102).

168

Li Y et al. The role of 14-3-3 dimerization in its modulation of the CaV2.2 channel.
Channels (Austin), 2007 Jan-Feb , 1 (1-2).

169

171

Llinás RR et al. Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice.
Proc. Natl. Acad. Sci. U.S.A., 2007 Nov 6 , 104 (17819-24).

172

Sandoval A et al. gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels.
Cell. Mol. Neurobiol., 2007 Nov , 27 (901-8).

173

Khanna R et al. A proteomic screen for presynaptic terminal N-type calcium channel (CaV2.2) binding partners.
J. Biochem. Mol. Biol., 2007 May 31 , 40 (302-14).

175

Buraei Z et al. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.
Neuropharmacology, 2007 Mar , 52 (883-94).

180

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

181

Khanna R et al. The presynaptic CaV2.2 channel-transmitter release site core complex.
Eur. J. Neurosci., 2007 Aug , 26 (547-59).

184

Dray A et al. Arthritis and pain. Future targets to control osteoarthritis pain.
Arthritis Res. Ther., 2007 , 9 (212).

186

189

Berkefeld H et al. BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling.
Science, 2006 Oct 27 , 314 (615-20).

190

Castiglioni AJ et al. Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels.
J. Physiol. (Lond.), 2006 Oct 1 , 576 (119-34).

196

198

Gao L et al. CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels.
Biochem. Biophys. Res. Commun., 2006 Jul 14 , 345 (1606-10).

202

McDavid S et al. G-proteins modulate cumulative inactivation of N-type (Cav2.2) calcium channels.
J. Neurosci., 2006 Dec 20 , 26 (13373-83).

204

211

Helton TD et al. Neuronal L-type calcium channels open quickly and are inhibited slowly.
J. Neurosci., 2005 Nov 2 , 25 (10247-51).

212

Agler HL et al. G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels.
Neuron, 2005 Jun 16 , 46 (891-904).

214

Richman RW et al. RGS12 interacts with the SNARE-binding region of the Cav2.2 calcium channel.
J. Biol. Chem., 2005 Jan 14 , 280 (1521-8).

215

Yang SN et al. Beta-cell CaV channel regulation in physiology and pathophysiology.
Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).

216

Dekker LV et al. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells.
Eur. J. Pharmacol., 2005 Dec 28 , 528 (52-8).

218

Winquist RJ et al. Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain.
Biochem. Pharmacol., 2005 Aug 15 , 70 (489-99).

226

Cabrera-Vera TM et al. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.
Proc. Natl. Acad. Sci. U.S.A., 2004 Nov 16 , 101 (16339-44).

231

Thaler C et al. Cumulative inactivation of N-type CaV2.2 calcium channels modified by alternative splicing.
Proc. Natl. Acad. Sci. U.S.A., 2004 Apr 13 , 101 (5675-9).

234

Richman RW et al. Mapping of RGS12-Cav2.2 channel interaction.
Meth. Enzymol., 2004 , 390 (224-39).

235

Liang H et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family.
Neuron, 2003 Sep 11 , 39 (951-60).

237

241

Carlson AE et al. CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm.
Proc. Natl. Acad. Sci. U.S.A., 2003 Dec 9 , 100 (14864-8).

248

De Laet A et al. Immunohistochemical localization of voltage-activated calcium channels in the rat oesophagus.
Neurogastroenterol. Motil., 2002 Apr , 14 (173-81).

255

256

Carter AJ et al. Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.
Proc. Natl. Acad. Sci. U.S.A., 2000 Apr 25 , 97 (4944-9).

257

BIII 277CL. BIII 277, BIII 281CL.
Drugs R D, 1999 Jan , 1 (18-9).

259

260

262

Carter AJ et al. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
J. Pharmacol. Exp. Ther., 1995 Dec , 275 (1382-9).

264

Wakamori M et al. Distinctive functional properties of the neuronal BII (class E) calcium channel.
Recept. Channels, 1994 , 2 (303-14).